SMEDDS (Self-MicroEmulsifying Drug Delivery System) As An Intraurethral Prostaglandin E1 Delivery System |
Lee, Sang-Kil
(Department of Pharmaceutical Engineering, Inje University)
Jeon, Sang-Ok (Department of Pharmaceutical Engineering, Inje University) Kang, Jae-Seon (Department of Pharmaceutical Engineering, Inje University) Lee, Jae-Hwi (College of Pharmacy, Chung-Ang University) Choi, Young-Wook (College of Pharmacy, Chung-Ang University) |
1 | R. Igarashi, T. Takenenage and T. Matsuda, Distribution of lipid microsphere preparation, Adv. Drug Deliv. Rev., 20, 147-154 (1996) DOI ScienceOn |
2 | C.W. Pouton, Self-emulsifying drug delivery systems: Assessment of the efficiency of emulsification, Int. J. Pharm., 27, 335-348 (1985) DOI ScienceOn |
3 | R. Virag, K. Shoukry, J. Floresco, E Nollet and E. Greco, Intracavemous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases, The J. Urol., 145, 287-293 (1991) DOI |
4 | H.P. Nathan, W.J.G Hellstrom, F.E. Kaiser, R.F. Labasky, T.F. Lue, W.E. Nolten, P.C. Norwood, C.A. Peterson, R. Shabsigh, P.Y. Tam, V.A. Place and N. Gesundheit, Treatment of men with erectile dysfunction with transurethral alprostadil, N. Engl. J. Med., 336, 1-7 (1997) DOI ScienceOn |
5 | P. Werthman and J. Rajfer, Muse therapy: Preliminary clinical observations, Urol., 50, 809-811 (1997) DOI ScienceOn |
6 | M. Waldhauser and P. Schramek, Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction, The J. Urol., 140, 525-527 (1988) DOI |
7 | S.B. Levine, S.E. Althof, L.A. Turner, C.B. Risen, Bodner D.R., Kursh E.D. and M.L. Resnick, Side effects of self-administration of intracavemous papaverine and phentolamine for the treatment of impotence, The J. Urol., 141, 54-57 (1989) DOI |
8 | E.D. Kim and K.T. Mcvary, Topical prostaglandin E1 for the treatment of erectile dysfunction, The J. Urol., 153, 1828-1830 (1995) DOI ScienceOn |
9 | M. Maggi, S. Filippi and F. Ledda, Erectile dysfunction: from biochemical pharmacology to advances in medical therapy, Eur. J. Endocrinol., 143, 143-154 (2000) DOI |
10 | L.S. Palmer, M. Valcic and A. Melman, Characterization of cyclic AMP accumulation in cultured human corpus cavernosum smooth muscle cells, J. Urol., 152, 1308-1314 (1994) DOI |
11 | K.C. Lee and P.P. Deluca, Simultaneous determination of prostaglandin E1, A1, and B1 by reversed-phase high-performance liquid chromatography for the kinetic studies of prostaglandin E1 in solution, J. Chromatogr., 555, 73-80 (1991) DOI ScienceOn |
12 | N.H. Shah, M.T. Carvajal, C.I. Patel, M.H. Infeld and A.W. Malick, Self- emulsifying drug delivery systems with polygIycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, Int. J. Pharm., 106, 15-23 (1994) DOI ScienceOn |
13 | M.J. Lawrence and G.D. Rees, Microemulsion-based media as novel drug delivery systems, Adv. Drug Deliv. Rev., 45, 89-121 (2000) |
14 | S.M. Khoo, A.J. Humberstone, C.J.H. Porter, G.A Edward and W.N. Charman, Formulation design and biocompatibility assessment of lipidic self-emulsifying formulations of halofantrine, Int. J. Pharm., 167, 155-164 (1998) DOI ScienceOn |
15 | D.L. Teagarden, B.D. Anderson and W.J. Peter, Dehydration kinetics of prostaglandin in a lipid emulsion, Pharm. Res., 6, 210-215 (1989) DOI |
16 | Technical Leaflet; Cremophor ELP, BASF 1997 |
17 | Technical Leaflet; Cremophor EL, BASF 1997 |
18 | Y. Mizushima, Lipid microspheres (Lipid emulsions) as a drug carriers-overview, Adv. Drug Deliv. Rev., 20, 113-115 (1996) DOI ScienceOn |